Atomo Diagnostics Limited announced the appointment of Dr. Cheri Walker as an independent Non-Executive Director. Based in the US, Dr Walker brings more than two decades of experience working in life science tools and medical diagnostics with companies ranging from startups to global businesses. Dr Walker is currently engaged by Rhinostics Inc. as President and Chief Executive Officer.

She has held various operating and corporate development roles at bell weather companies, including Invitrogen, QIAGEN, Charles River Laboratories, and most recently as senior vice president of corporate development at Abcam. Dr Walker has significant health industry commercialisation experience, holding the position of Chief Financial Officer at Kailos Genetics, currently serves a director for Cell IDx, and consulting with many early-stage companies. Dr Walker began her career as a stock analyst with Deutsche Bank, covering life science tools companies.

Dr. Walker holds a PhD in Human and Molecular Genetics from Baylor College of Medicine and a BA in Biology from Swarthmore College.